Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	44.70	-89.21	-161.32
Graham Fair Price	inf	0.00	0.67
PEG	inf	0.00	-23.27
Price/Book	inf	0.00	-2.25
Price/Cash Flow	inf	0.00	-16121.56
Prices/Earnings	inf	0.00	-45.33
Price/Sales	inf	0.00	81.14
Price/FCF	inf	0.00	-16121.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-93.03	< 0.005	0.13
Operating Margin	49.71	-0.40	-0.79
ROA	-19.22	-0.02	-0.02
ROE	0.01	0.01	14.32
ROIC	-0.06	-0.07	-23.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	-34.98
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.06	0.31	412.68
EPS QOQ	-0.02	1.00	5033.33
FCF QOQ	0.99	0.18	-82.27
Revenue QOQ	0.20	0.36	86.18
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	157.75	99.10	-37.18
Days Sales Outstanding (DSO)	627.79	421.88	-32.80
Inventory Turnover	0.57	0.91	59.19
Debt/Capitalization	5.55	5.89	6.29
Quick Ratio	0.12	0.11	-9.46
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	-1.26	0.00	inf
Cash	0.01	0.00	inf
Capex	< 0.005	0.00	inf
Free Cash Flow	< 0.005	0.00	inf
Revenue	0.03	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.16	0.15	-6.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-56.38	-89.21	-58.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating